Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Noordman, B.J.; Spaander, M.C.W.; Valkema, R.; Wijnhoven, B.P.L.; Henegouwen, M.I.V.; Shapiro, J.; ... ; SANO study grp (2018)

Article / Letter to editor

• All authors: Noordman, B.J.; Spaander, M.C.W.; Valkema, R.; Wijnhoven, B.P.L.; Henegouwen, M.I.V.; Shapiro, J.; Biermann, K.; Gaast, A. van der; Hillegersberg, R. van; Hulshof, M.C.C.M.; Krishnadath, K.K.; Lagarde, S.M.; Nieuwenhuijzen, G.A.P.; Oostenbrug, L.E.; Siersema, P.D.; Schoon, E.J.; Sosef, M.N.; Steyerberg, E.W.; Lanschot, J.J.B. van; SANO study grp
• Date: 2018-07-31
• Journal: The Lancet Oncology
• Volume: 19
• Issue: 7
• Pages: 965 - 974
• DOI: doi:10.1016/S1470-2045(18)30201-8